Would you re-test cagrilintide after sixteen weeks at room temperature, or accept the original certificate?

Details up front: cagrilintide · sixteen weeks · room temperature.

I would rather over-plan the first cycle and simplify later.

I am prepared to do the work if someone can tell me which work matters.

What is the minimum version of this that is still defensible?

The practical consequence is that spot-testing one vial from a new supplier is better than assuming they are all the same.

If the entire lot failed qualification, a retest on a different vial is sometimes done, but reporting a retest result under the same lot number is misleading.

The sample size determination requires choosing a confidence level and an acceptable error rate, and the smaller the error rate you want, the larger your sample must be.

The limitation is that you cannot know for certain without testing every vial, and you almost never can afford to do that.

Assume segregation is possible, and design your sampling to catch it if it exists.

It helps to be literal here: batch testing establishes what can be claimed about the lot as a whole, and the sample size determines how much you can actually claim.

Testing a vial that has been open in the lab for three months is testing aged material, not the fresh lot, and the result should be explicitly noted as a retest.

More usefully, for a quantitative result like content, the acceptable range determines how many vials you need to test to establish the lot complies.

Worth noting that thermal excursions during shipping affect different vials differently, so the lot may not be homogeneous even if it left the factory that way.

If testing multiple vials, state how many you tested and why you chose those vials.

A certificate that reports one test result on one vial extrapolates to claim that all two hundred vials in the lot are identical, which is an assumption worth questioning.

Published segregation failures show that even modern automated processes sometimes produce lots with measurable vial-to-vial variation.

The practical summary: a lot number without a sampling statement is a lot number without meaning.

edited 29 Sept 2024 by h_villanueva — removed a claim I could not source

Thermal history during shipping is different for every vial, so a lot that experienced thermal abuse may have internal variation even if it was originally homogeneous.

Under AQL sampling plans, testing two vials from a fifty-vial lot gives you an operating characteristic curve that tells you what risks you are accepting.

Published data on lot homogeneity from manufacturers who sample multiple vials consistently find variation below the published specifications, suggesting the sampling plans work.

One qualification: testing more vials gives better confidence, but at some point the cost outweighs the benefit.

Assume segregation is possible, and design your sampling to catch it if it exists.